Personalized immunization against Mpox Clades I and Ib: Strategies to combat the emerging epidemic

Mpox, formerly known as monkeypox, is a zoonotic virus of the Orthopoxvirus genus, with recent outbreaks of Clade I and Ib in Central Africa presenting a considerable global health threat. This study reviews current Mpox immunization approaches, focusing on the MVA-BN, LC16-KMB, and OrthopoxVac vacc...

Full description

Saved in:
Bibliographic Details
Main Authors: Deepak Kumar, Rishabha Malviya, Shriyansh Srivastava, Sathvik Belagodu Sridhar, Sirajunisa Talath, Javedh Shareef, Bhupendra G. Prajapati
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Infectious Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772431X2500005X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850024169242099712
author Deepak Kumar
Rishabha Malviya
Shriyansh Srivastava
Sathvik Belagodu Sridhar
Sirajunisa Talath
Javedh Shareef
Bhupendra G. Prajapati
author_facet Deepak Kumar
Rishabha Malviya
Shriyansh Srivastava
Sathvik Belagodu Sridhar
Sirajunisa Talath
Javedh Shareef
Bhupendra G. Prajapati
author_sort Deepak Kumar
collection DOAJ
description Mpox, formerly known as monkeypox, is a zoonotic virus of the Orthopoxvirus genus, with recent outbreaks of Clade I and Ib in Central Africa presenting a considerable global health threat. This study reviews current Mpox immunization approaches, focusing on the MVA-BN, LC16-KMB, and OrthopoxVac vaccines. MVA-BN vaccination has been successful in lowering infection risks, particularly in high-risk individuals and is widely used in the USA. LC16-KMB is recommended by the World Health Organization for prevention in afflicted regions. OrthopoxVac, a newer vaccination authorized in Russia, provides wide protection. Adapting vaccination approaches based on epidemiology in particular areas is critical for minimizing Mpox outbreaks.
format Article
id doaj-art-ef9fc8661f724358bf5b153a36903e28
institution DOAJ
issn 2772-431X
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Infectious Medicine
spelling doaj-art-ef9fc8661f724358bf5b153a36903e282025-08-20T03:01:11ZengElsevierInfectious Medicine2772-431X2025-03-014110016610.1016/j.imj.2025.100166Personalized immunization against Mpox Clades I and Ib: Strategies to combat the emerging epidemicDeepak Kumar0Rishabha Malviya1Shriyansh Srivastava2Sathvik Belagodu Sridhar3Sirajunisa Talath4Javedh Shareef5Bhupendra G. Prajapati6Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida 203201, IndiaDepartment of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida 203201, India; Galgotias Multi-Disciplinary Research & Development Cell (G-MRDC), Galgotias University, Greater Noida-201308, U.P., India; Corresponding author.Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida 203201, India; Corresponding author.RAK College of Pharmacy, RAK Medical & Health Sciences University, Ras al Khaimah 11172, United Arab EmiratesRAK College of Pharmacy, RAK Medical & Health Sciences University, Ras al Khaimah 11172, United Arab EmiratesRAK College of Pharmacy, RAK Medical & Health Sciences University, Ras al Khaimah 11172, United Arab EmiratesDepartment of Pharmaceutics, Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Mehsana 384012, IndiaMpox, formerly known as monkeypox, is a zoonotic virus of the Orthopoxvirus genus, with recent outbreaks of Clade I and Ib in Central Africa presenting a considerable global health threat. This study reviews current Mpox immunization approaches, focusing on the MVA-BN, LC16-KMB, and OrthopoxVac vaccines. MVA-BN vaccination has been successful in lowering infection risks, particularly in high-risk individuals and is widely used in the USA. LC16-KMB is recommended by the World Health Organization for prevention in afflicted regions. OrthopoxVac, a newer vaccination authorized in Russia, provides wide protection. Adapting vaccination approaches based on epidemiology in particular areas is critical for minimizing Mpox outbreaks.http://www.sciencedirect.com/science/article/pii/S2772431X2500005XOrthopoxvirusClade IbMVA-BNLC16-KMBOrthopoxVacGlobal outbreak
spellingShingle Deepak Kumar
Rishabha Malviya
Shriyansh Srivastava
Sathvik Belagodu Sridhar
Sirajunisa Talath
Javedh Shareef
Bhupendra G. Prajapati
Personalized immunization against Mpox Clades I and Ib: Strategies to combat the emerging epidemic
Infectious Medicine
Orthopoxvirus
Clade Ib
MVA-BN
LC16-KMB
OrthopoxVac
Global outbreak
title Personalized immunization against Mpox Clades I and Ib: Strategies to combat the emerging epidemic
title_full Personalized immunization against Mpox Clades I and Ib: Strategies to combat the emerging epidemic
title_fullStr Personalized immunization against Mpox Clades I and Ib: Strategies to combat the emerging epidemic
title_full_unstemmed Personalized immunization against Mpox Clades I and Ib: Strategies to combat the emerging epidemic
title_short Personalized immunization against Mpox Clades I and Ib: Strategies to combat the emerging epidemic
title_sort personalized immunization against mpox clades i and ib strategies to combat the emerging epidemic
topic Orthopoxvirus
Clade Ib
MVA-BN
LC16-KMB
OrthopoxVac
Global outbreak
url http://www.sciencedirect.com/science/article/pii/S2772431X2500005X
work_keys_str_mv AT deepakkumar personalizedimmunizationagainstmpoxcladesiandibstrategiestocombattheemergingepidemic
AT rishabhamalviya personalizedimmunizationagainstmpoxcladesiandibstrategiestocombattheemergingepidemic
AT shriyanshsrivastava personalizedimmunizationagainstmpoxcladesiandibstrategiestocombattheemergingepidemic
AT sathvikbelagodusridhar personalizedimmunizationagainstmpoxcladesiandibstrategiestocombattheemergingepidemic
AT sirajunisatalath personalizedimmunizationagainstmpoxcladesiandibstrategiestocombattheemergingepidemic
AT javedhshareef personalizedimmunizationagainstmpoxcladesiandibstrategiestocombattheemergingepidemic
AT bhupendragprajapati personalizedimmunizationagainstmpoxcladesiandibstrategiestocombattheemergingepidemic